YARWの配当利回りは？

YARROW BIOSCIENCE INCの配当利回りは0.00%です。

YARWは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

YARWはどのセクターに属しますか？

YARROW BIOSCIENCE INCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

YARW (NASDAQ) 株価分析 | YARROW BIOSCIENCE INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: -)

YARW AI Analysis Summary

Our AI summary for YARW: YARROW BIOSCIENCE INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, a dividend yield of 0.00%. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

YARW

YARROW BIOSCIENCE INC

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 35.02

2.03 (6.15%) Day Change

Watchlist Portfolio Compare Chart

0.00%

Div Yield

YARROW BIOSCIENCE INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 35.02 Price 2.03 (6.15%) Day Change	NEWS SCORE: N/A

Not enough data to analyze.

No price data to display chart for the last 3-months of this stock

N/A

QUALITY

Signal: N/A

Signal Description: N/A

Reason: N/A

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	35.02
PBV / Sector	20.59 / 5.20
Earning Per Share	N/A

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	0.65 M GREAT
Average 1W Daily Value	0.65 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	N/A / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	N/A / 27.02
ROA Average (%) / Sector	N/A / -368.17
ROA Change Average (%) / Sector	N/A / 5,404.12
ROE (%) / Sector	N/A / 3.47
ROE Average (%) / Sector	N/A / 6.51
ROE Change Average (%) / Sector	N/A / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date
Symbol	YARW
Name	YARROW BIOSCIENCE INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	168.62 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 40 10 th Avenue, New York, NY, United States, 10014

Phone: -

Website: https://www.yarrowbioscience.com

Employees: -

Sector: Healthcare >> Biotechnology

Description: Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.